All
Data for anti-aging skincare lags behind consumer interest
December 1st 2007The antiaging skincare market continues to grow with topical and oral products containing novel ingredients being rapidly introduced. However, scientific evidence to demonstrate effects of these agents on the skin is often lacking.
JAAD online features help readers stay current in information age
December 1st 2007The online version of the Journal of the American Academy of Dermatology (JAAD) provides valuable aids for handling the challenges presented by the growing problem of information overload, according to Jeffrey D. Bernhard, M.D., editor.
Government grants help restore New Orleans' healthcare workforce
December 1st 2007The Louisiana Department of Health and Hospitals is awarding physicians and other needed health care providers who meet certain criteria and agree to work in Greater New Orleans for three years or more grants of up to $110,000 each. The program, however, has yet to secure a dermatologist.
Expert witnesses: Who Can Testify Against Me?
December 1st 2007Dr. Skin has been practicing dermatology for 20 years. He performs both medical and cosmetic treatments. Three years ago, he chose to desiccate plantar warts on the foot of a 32-year-old diabetic athlete. The sites became infected and, ultimately, an amputation of the patient's foot was required.
FDA, Cephalon issue revised warnings about serious reactions to Provigil
November 6th 2007Frazer, Pa. - The Food and Drug Administration (FDA) and Cephalon, based here, have issued new warnings in the prescribing information for Provigil regarding the risk of severe reactions - including one death, HealthDay News reports.
Theravance works to resolve FDA issues on new skin-infection treatment
November 6th 2007South San Francisco, Calif. - Theravance Inc., based here, and partner Astellas Pharma US Inc., an affiliate of Japan’s Astellas Pharma Inc., have received a Food and Drug Administration approvable letter asking for additional clinical information on the drug telavancin to treat skin infections caused by gram-positive bacteria, news source rttnews.com reports.
Stem cell study shows potential for successful treatment of genetic skin disorders
November 6th 2007Modena, Italy - Researchers at the University of Modena and Reggio Emilia have shown how stem cells not only can be used to treat damaged eyes but, in combination with gene therapy, can treat a rare and debilitating skin disease, Sciencedaily.com reports.
Nurses better at treating childhood eczema than dermatologists, study finds
November 6th 2007Melbourne, Australia - An Australian study suggests that nurses may be more effective in reducing the severity of atopic eczema in infants, children and adolescents than those treated by a dermatologist, ReutersHealth reports.
Student develops computer model to help predict melanoma’s potential spread
November 6th 2007Auckland, New Zealand - A student at Auckland University’s Maurice Wilkins Centre has developed an interactive computer model that doctors will be able to use as a tool to predict how cancerous cells from melanoma will move throughout the body, the New Zealand Herald reports.
Three proven time management techniques
November 1st 2007If your vision of getting out of the office on time is two hours after your clinic has ended, or you haven't had more than five minutes for lunch in more than a year, it's time for you to improve your efficiency. Try time management techniques proven to get you back on schedule. These changes won't cost you money, but they do require your commitment to change some work habits.
Antimicrobial peptides research suggests novel tx of chronic skin conditions
November 1st 2007New research of antimicrobial peptides suggests that they may play a role in protecting against infection in some chronic skin conditions such as psoriasis, while in others, such as atopic dermatitis, patients remain vulnerable to infection
Study suggests HPV vaccine offers cross-protection against 10 additional strains of the virus
November 1st 2007Merck's Gardasil offers cross-protection against up to 10 additional types of HPV not represented in the vaccine. Varying degrees of protection may be related to antibodies, memory B cells. Niche-filling is unlikely to occur with HPV, due to its very stable genome.
Hydrogen peroxide vapor kills MRSA, other environmental pathogens
November 1st 2007Hydrogen peroxide vapor has demonstrated an excellent ability to eradicate methicillin-resistant Staphylococcus aureus (MRSA) environmental contamination, according to a poster presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago in September.
Leishmaniasis outbreak: North texas cases signal endemic spread
November 1st 2007Dermatologists have long known to suspect leishmaniasis in patients in South Texas, near the Mexican border. Elsewhere in the United States, dermatologists should suspect that persistent sores in patients who have traveled to South or Central America, Mexico or the Middle East could also be caused by the protozoan Leishmania.
Apointment delays longer for suspicious moles than for Botox tx
November 1st 2007Patients waiting to have a mole examined will find themselves in a longer queue than patients waiting for cosmetic botulinum toxin (Botox, Allergan) injections, according to research results published in the Journal of the American Academy of Dermatology.